Challenges of cell therapy manufacturing: automation and disposables – the hand and the glove
May
10
2018
On demand

Challenges of cell therapy manufacturing: automation and disposables – the hand and the glove

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Challenges of cell therapy manufacturing: automation and disposables – the hand and the glove

Watch this On Demand webinar which explores the close relationship between automation and disposables as critical elements that allow Cell Therapy companies to manufacture cost-effective therapies. We’ll be hearing from Natasha Boghosian, Product Manager for Cell Therapy at Saint-Gobain, USA and Brian Hanrahan, Program Manager at Invetech as they discuss the critical considerations for successful cell therapy automation, including materiel selection, system design, and validation.

This webinar provides insight into:

  • How to optimize material selection for your single-use system;
  • The critical steps to successful validation;
  • The future of automation and emerging technologies.
Natasha Boghosian
Natasha Boghosian
Consultant at Integrated Project Management Company, Inc.
Natasha Boghosian is the Product Manager for Cell Therapy within Saint-Gobain’s Bioprocessing Solutions business unit. Natasha joined Saint-Gobain in 2012 and previously served as a Process Development Engineer within the CertainTeed division and a Research Engineer within the Performance Plastics division. Natasha received her B.S. in Chemical Engineering from the Pennsylvania State University where she supplemented her studies through research internships in bioengineering and immunology
Brian Hanrahan
Brian Hanrahan
Biotech Program Director at StarFish Medical
Brian Hanrahan has more than 15 years of product development experience across the biomedical and cell therapy industries. In his current role, Brian is the Manager of Invetech’s Cell Therapy Group in San Diego, CA, USA, helping cell and advanced therapy companies across the globe realize clinical and commercial-scale cGMP manufacturing solutions. Brian has been a key contributor in building Invetech’s cell and advanced therapy capabilities and continues to have a deep involvement in projects ranging from the development of cell separation instruments to single-use, automated cell therapy production systems. Brian has a bachelor’s degree in Applied Science from RMIT University in Australia.

SPEAKERS

Natasha Boghosian
Natasha Boghosian
Consultant at Integrated Project Management Company, Inc.
Brian Hanrahan
Brian Hanrahan
Biotech Program Director at StarFish Medical

You might also like

From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development

From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development

Audrey Chang, Joe Newcome
10 December
in 6
Days
Register
Automated and streamlined manufacturing of TIL therapies

Automated and streamlined manufacturing of TIL therapies

Ian Hardy, Lars Ny
16 October
Watch
Rapid CAR-T cells: Accelerating manufacturing to enable fast transition of CAR-T cell therapies to the clinic

Rapid CAR-T cells: Accelerating manufacturing to enable fast transition of CAR-T cell therapies to the clinic

Tamara Laskowski, Kelly Purpura
7 December 2023
Watch
Overcoming challenges in cell therapy production: rapid sterility testing

Overcoming challenges in cell therapy production: rapid sterility testing

Seth Peterson
13 March
Watch
Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes

Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek
27 August
Watch